脊髓空洞-蛛网膜下腔分流术治疗Chiari I型畸形减压后持续性脊髓空洞的手术结果
本研究回顾性评估脊髓空洞-蛛网膜下腔分流术(SSS)治疗Chiari I型畸形枕骨大孔减压(FMD)后持续性脊髓空洞的临床与影像学结局。21例患者接受SSS,改良Japanese骨科协会(mJOA)评分中位改善3分(满分17分),总体改善11.8%(95%CI 5.9-17.6,P<0.001),脊髓空洞面积改善76.3%(95%CI 65.0-87.7,P<0.001),脊髓空洞跨度改善36.4%(95%CI 21.8-50.9,P=0.05)。作者认为,由经验丰富的神经外科医生选择性实施时,SSS是安全有效的手术治疗。
要点
- 21例患者接受SSS,mJOA评分中位改善3分,总体改善11.8%(95%CI 5.9-17.6,P<0.001)。
- 术后MRI显示除1例脊髓空洞无变化外,其余患者脊髓空洞均缩小,面积改善76.3%,跨度改善36.4%。
- 2例轻微手术并发症(伤口裂开、术后后凸)均需翻修手术,无重大并发症或死亡。
核心结论
- 对于Chiari I型畸形FMD后持续性、复发性或增大的脊髓空洞,由经验丰富的神经外科医生选择性实施SSS是安全有效的手术治疗。
研究设计与样本
- 回顾性数据收集,评估SSS治疗FMD后持续性脊髓空洞的临床与影像学结局,共纳入21例患者(14例女性,66.7%),SSS与FMD同期或后期进行。
主要发现
- mJOA评分中位变化为改善3分(满分17分),平均随访24.9个月;总体改善百分比为11.8%(95%CI 5.9-17.6,P<0.001)。
- 术后MRI显示除1例脊髓空洞无变化外,其余患者均见脊髓空洞缩小;脊髓空洞面积改善76.3%(95%CI 65.0-87.7,P<0.001),脊髓空洞跨度改善36.4%(95%CI 21.8-50.9,P=0.05)。
- 2例轻微手术并发症:伤口裂开和术后后凸,均需翻修手术;无重大并发症或死亡。
关键数值与推荐
- mJOA评分中位改善3分(满分17分),总体改善11.8%(95%CI 5.9-17.6,P<0.001)。
- 脊髓空洞面积改善76.3%(95%CI 65.0-87.7,P<0.001),脊髓空洞跨度改善36.4%(95%CI 21.8-50.9,P=0.05)。
临床怎么用
- 作者认为,对于Chiari I型畸形FMD后持续性、复发性或增大的脊髓空洞,由经验丰富的神经外科医生选择性实施SSS是安全有效的手术治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Approximately 30% of patients treated with foramen magnum decompression (FMD) for Chiari I-associated syringomyelia will show persistence, recurrence, or progression of the syrinx. OBJECTIVE: This study evaluates the clinical and radiologic outcomes of syringo-subarachnoid shunt (SSS) as the treatment for persistent syringomyelia after FMD. METHODS: Data were collected retrospectively. The primary outcome measurement was neurologic function (assessed with the Modified Japanese Orthopedic Association [mJOA] scale). Secondary outcome measurements were surgical complications, reoperation rate, and syrinx status on magnetic resonance imaging (MRI). RESULTS: Twenty-one patients (14 females [66.7%]) underwent SSS, either concurrent to the FMD or at a later stage. Two minor surgical complications were seen: a wound dehiscence and postoperative kyphosis, both requiring revision surgery. No major complication or mortality occurred. The median change in the mJOA score was an improvement of 3 out of a possible 17 points on the scale (mean follow-up, 24.9 months). Expressed as a percentage, overall improvement was 11.8% (95% confidence interval [CI], 5.9-17.6; P < 0.001). On postoperative MRI, shrinkage of the syrinx was seen in all but 1 patient in whom the syrinx remained unchanged. Expressed as percentage, the improvement of the syrinx surface was 76.3% (95% CI, 65.0-87.7; P < 0.001), and the improvement of syrinx span was 36.4% (95% CI, 21.8-50.9; P = 0.05). CONCLUSION: SSS for persistent, recurrent, or increasing syrinx following FMD for Chiari I malformation is a safe and effective surgical treatment when performed selectively by an experienced neurosurgeon.
引用
- Soleman J, Roth J, Bartoli A, et al. Syringo-Subarachnoid Shunt for the Treatment of Persistent Syringomyelia Following Decompression for Chiari Type I Malformation: Surgical Results. World Neurosurg. 2017. PMID: 28807779. doi:10.1016/j.wneu.2017.08.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。